Antibody–drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment

Howard, David; Garcia-Parra, Jetzabel; Healey, Gareth; Amakiri, Cynthia; Margarit, Lavinia; Francis, Lewis; Gonzalez, Deya; Conlan, R. Steven; Conlan, Steve; Parra, Jezabel Garcia

doi:10.1098/rsfs.2016.0054

Journal article 22681 views

Antibody–drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment

David Howard, Jetzabel Garcia-Parra, Gareth Healey

, Cynthia Amakiri, Lavinia Margarit, Lewis Francis

, Deya Gonzalez

, R. Steven Conlan, Steve Conlan

, Jezabel Garcia Parra

Interface Focus, Volume: 6, Issue: 6, Start page: 20160054

Swansea University Authors: Gareth Healey , Lewis Francis , Deya Gonzalez , Steve Conlan , Jezabel Garcia Parra

Full text not available from this repository: check for access using links below.

Check full text

DOI (Published version): 10.1098/rsfs.2016.0054

Published in:	Interface Focus
ISSN:	2042-8898 2042-8901
Published:	2016
Online Access:	Check full text
URI:	https://cronfa.swan.ac.uk/Record/cronfa33095
Tags:	Add Tag No Tags, Be the first to tag this record!

first_indexed	2017-04-26T13:06:52Z
last_indexed	2018-02-09T05:21:43Z
id	cronfa33095
recordtype	SURis
fullrecord	<?xml version="1.0"?><rfc1807><datestamp>2017-11-14T14:14:20.1538503</datestamp><bib-version>v2</bib-version><id>33095</id><entry>2017-04-26</entry><title>Antibody–drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment</title><swanseaauthors><author><sid>5926519f89187489cfd5e1478aa188b1</sid><ORCID>0000-0001-9531-1220</ORCID><firstname>Gareth</firstname><surname>Healey</surname><name>Gareth Healey</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>10f61f9c1248951c1a33f6a89498f37d</sid><ORCID>0000-0002-7803-7714</ORCID><firstname>Lewis</firstname><surname>Francis</surname><name>Lewis Francis</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>bafdf635eb81280304eedf4b18e65d4e</sid><ORCID>0000-0002-1838-6752</ORCID><firstname>Deya</firstname><surname>Gonzalez</surname><name>Deya Gonzalez</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>0bb6bd247e32fb4249de62c0013b51cb</sid><ORCID>0000-0002-2562-3461</ORCID><firstname>Steve</firstname><surname>Conlan</surname><name>Steve Conlan</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>f0342a6c8de90d52996ac44f44908f68</sid><firstname>Jezabel</firstname><surname>Garcia Parra</surname><name>Jezabel Garcia Parra</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2017-04-26</date><deptcode>PMSC</deptcode><abstract/><type>Journal Article</type><journal>Interface Focus</journal><volume>6</volume><journalNumber>6</journalNumber><paginationStart>20160054</paginationStart><publisher/><issnPrint>2042-8898</issnPrint><issnElectronic>2042-8901</issnElectronic><keywords/><publishedDay>21</publishedDay><publishedMonth>10</publishedMonth><publishedYear>2016</publishedYear><publishedDate>2016-10-21</publishedDate><doi>10.1098/rsfs.2016.0054</doi><url/><notes/><college>COLLEGE NANME</college><department>Medicine</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>PMSC</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2017-11-14T14:14:20.1538503</lastEdited><Created>2017-04-26T12:44:43.6031502</Created><authors><author><firstname>David</firstname><surname>Howard</surname><order>1</order></author><author><firstname>Jetzabel</firstname><surname>Garcia-Parra</surname><order>2</order></author><author><firstname>Gareth</firstname><surname>Healey</surname><orcid>0000-0001-9531-1220</orcid><order>3</order></author><author><firstname>Cynthia</firstname><surname>Amakiri</surname><order>4</order></author><author><firstname>Lavinia</firstname><surname>Margarit</surname><order>5</order></author><author><firstname>Lewis</firstname><surname>Francis</surname><orcid>0000-0002-7803-7714</orcid><order>6</order></author><author><firstname>Deya</firstname><surname>Gonzalez</surname><orcid>0000-0002-1838-6752</orcid><order>7</order></author><author><firstname>R. Steven</firstname><surname>Conlan</surname><order>8</order></author><author><firstname>Steve</firstname><surname>Conlan</surname><orcid>0000-0002-2562-3461</orcid><order>9</order></author><author><firstname>Jezabel</firstname><surname>Garcia Parra</surname><order>10</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling	2017-11-14T14:14:20.1538503 v2 33095 2017-04-26 Antibody–drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment 5926519f89187489cfd5e1478aa188b1 0000-0001-9531-1220 Gareth Healey Gareth Healey true false 10f61f9c1248951c1a33f6a89498f37d 0000-0002-7803-7714 Lewis Francis Lewis Francis true false bafdf635eb81280304eedf4b18e65d4e 0000-0002-1838-6752 Deya Gonzalez Deya Gonzalez true false 0bb6bd247e32fb4249de62c0013b51cb 0000-0002-2562-3461 Steve Conlan Steve Conlan true false f0342a6c8de90d52996ac44f44908f68 Jezabel Garcia Parra Jezabel Garcia Parra true false 2017-04-26 PMSC Journal Article Interface Focus 6 6 20160054 2042-8898 2042-8901 21 10 2016 2016-10-21 10.1098/rsfs.2016.0054 COLLEGE NANME Medicine COLLEGE CODE PMSC Swansea University 2017-11-14T14:14:20.1538503 2017-04-26T12:44:43.6031502 David Howard 1 Jetzabel Garcia-Parra 2 Gareth Healey 0000-0001-9531-1220 3 Cynthia Amakiri 4 Lavinia Margarit 5 Lewis Francis 0000-0002-7803-7714 6 Deya Gonzalez 0000-0002-1838-6752 7 R. Steven Conlan 8 Steve Conlan 0000-0002-2562-3461 9 Jezabel Garcia Parra 10
title	Antibody–drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment
spellingShingle	Antibody–drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment Gareth Healey Lewis Francis Deya Gonzalez Steve Conlan Jezabel Garcia Parra
title_short	Antibody–drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment
title_full	Antibody–drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment
title_fullStr	Antibody–drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment
title_full_unstemmed	Antibody–drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment
title_sort	Antibody–drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment
author_id_str_mv	5926519f89187489cfd5e1478aa188b1 10f61f9c1248951c1a33f6a89498f37d bafdf635eb81280304eedf4b18e65d4e 0bb6bd247e32fb4249de62c0013b51cb f0342a6c8de90d52996ac44f44908f68
author_id_fullname_str_mv	5926519f89187489cfd5e1478aa188b1_*_Gareth Healey 10f61f9c1248951c1a33f6a89498f37d__Lewis Francis bafdf635eb81280304eedf4b18e65d4e__Deya Gonzalez 0bb6bd247e32fb4249de62c0013b51cb__Steve Conlan f0342a6c8de90d52996ac44f44908f68_**_Jezabel Garcia Parra
author	Gareth Healey Lewis Francis Deya Gonzalez Steve Conlan Jezabel Garcia Parra
author2	David Howard Jetzabel Garcia-Parra Gareth Healey Cynthia Amakiri Lavinia Margarit Lewis Francis Deya Gonzalez R. Steven Conlan Steve Conlan Jezabel Garcia Parra
format	Journal article
container_title	Interface Focus
container_volume	6
container_issue	6
container_start_page	20160054
publishDate	2016
institution	Swansea University
issn	2042-8898 2042-8901
doi_str_mv	10.1098/rsfs.2016.0054
document_store_str	0
active_str	0
published_date	2016-10-21T03:40:44Z
_version_	1763751854419738624
score	11.037166

Antibody–drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment

Similar Items